A trade-off: Antimicrobial resistance and COVID-19

As we combat the COVID-19 pandemic, both the prescription of antimicrobials and the use of biocidal agents have increased in many countries. Although these measures can be expected to benefit existing people by, to some extent, mitigating the pandemic's effects, they may threaten long-term well...

Full description

Saved in:  
Bibliographic Details
Main Author: Johnson, Tess (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Wiley-Blackwell 2021
In: Bioethics
Year: 2021, Volume: 35, Issue: 9, Pages: 947-955
IxTheo Classification:KAJ Church history 1914-; recent history
NCH Medical ethics
ZA Social sciences
Further subjects:B pandemic ethics
B Distributive Justice
B Covid-19
B antimicrobial resistance
B Trade-off
Online Access: Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000caa a22000002 4500
001 1776574761
003 DE-627
005 20220202101027.0
007 cr uuu---uuuuu
008 211110s2021 xx |||||o 00| ||eng c
024 7 |a 10.1111/bioe.12928  |2 doi 
035 |a (DE-627)1776574761 
035 |a (DE-599)KXP1776574761 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Johnson, Tess  |e VerfasserIn  |4 aut 
245 1 2 |a A trade-off: Antimicrobial resistance and COVID-19 
264 1 |c 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a As we combat the COVID-19 pandemic, both the prescription of antimicrobials and the use of biocidal agents have increased in many countries. Although these measures can be expected to benefit existing people by, to some extent, mitigating the pandemic's effects, they may threaten long-term well-being of existing and future people, where they contribute to the problem of antimicrobial resistance (AMR). A trade-off dilemma thus presents itself: combat COVID-19 using these measures, or stop using them in order to protect against AMR. Currently, I argue, we are choosing to continue with these measures, and thus to prioritize combatting COVID-19, without adequate ethical reflection on the AMR-associated costs of these measures. I discuss the magnitude of the possible costs and benefits involved in making the trade-off in favour of COVID-19, and their distribution. I highlight two salient aspects of distribution that can help determine whether combatting COVID-19 whilst exacerbating AMR produces justly distributed costs and benefits: distribution between current and future populations, and distribution between existing geographical populations. Adopting this account, I argue that based on the magnitude and distribution of costs and benefits of combatting COVID-19, we have good reason to rethink this trade-off, and instead consider prioritizing protecting current and future people against AMR, but jettisoning measures against COVID-19 that also exacerbate AMR. 
601 |a COVID-19 
650 4 |a Trade-off 
650 4 |a pandemic ethics 
650 4 |a Distributive Justice 
650 4 |a Covid-19 
650 4 |a antimicrobial resistance 
652 |a KAJ:NCH:ZA 
773 0 8 |i Enthalten in  |t Bioethics  |d Oxford [u.a.] : Wiley-Blackwell, 1987  |g 35(2021), 9, Seite 947-955  |h Online-Ressource  |w (DE-627)271596708  |w (DE-600)1480658-7  |w (DE-576)078707986  |x 1467-8519  |7 nnns 
773 1 8 |g volume:35  |g year:2021  |g number:9  |g pages:947-955 
856 |u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bioe.12928  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [open (via crossref license)] 
856 4 0 |u https://doi.org/10.1111/bioe.12928  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12928  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4000481215 
LOK |0 003 DE-627 
LOK |0 004 1776574761 
LOK |0 005 20220202101027 
LOK |0 008 211110||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2021-11-09#5C54AD4184391FCC26CDA22E3323E5F6C21B699D 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a zota 
LOK |0 936ln  |0 1550736558  |a NCH 
LOK |0 936ln  |0 1442044640  |a KAJ 
LOK |0 936ln  |0 1442053771  |a ZA 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw 
REL |a 1 
SUB |a REL